Skip to content

Study · Not a test of the peptide alone · 2010

1 result

[Possibilities of the application of antioxidants and antihypoxants in a complex therapy of obsessive conditions in different mental disorders].

Podsevatkin VG, Kiriukhina SV

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2010

PMID20517227 (opens in a new tab)PepBankPUB-20517227

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymogen (oglufanide).

  1. 01HumanNot a test of Thymogen (oglufanide) aloneNon-randomized trialEfficacy outcome

    In patients with obsessive-compulsive neurosis or generalized tic disease, mexidol, thymogen and hyperbaric oxygenation had greater psychopharmacological effects than traditional therapy.

    In plain wordsIn patients with obsessive-compulsive neurosis or tic disease, mexidol, thymogen and hyperbaric oxygenation had greater psychopharmacological effects than traditional therapy.

    Outcome
    IncreasePsychopharmacological effect
    Study

    n: not reported in source

    Comparator
    Traditional therapy with neuroleptics and benzodiazepine anxiolytics
    Outcome group
    Anxiety and mood · Mental health and mood

    Source sentences

    Summary
    The complex psychopharmacological effect of mexidol, thymogen and hyperbaric oxygenation was significantly higher compared to traditional therapy (neuroleptics and benzodiazepine anxiolytics) applied to patients with OCN and GTD.
    1 context sentence
    Summary · context
    Based on the study of 84 patients with a syndrome of persistence within obsessive-compulsive neurosis (OCN) and generalized tic disease (GTD), we found the dysfunction of humoral and cellular immune reactions with the disturbance of regulation of hypophysis-adrenal and hypophysis-thyroid systems.

    In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.